The influence of mortality rate from membrane flux for end-stage renal disease: A meta-analysis - 04/02/17
Abstract |
To evaluate the influence of the high-flux hemodialysis (HFHD) and the low-flux hemodialysis (LFHD) on mortality rate for end-stage renal disease (ESRD). Four electronic databases including PubMed, EMBASE, the Cochrane Library, and ClinicalTrails were searched to identify relevant randomized clinical trials up to 31 August 2015. Seven studies enrolling a total of 4412 patients were included in this meta-analysis. For all-cause mortality comparing with LFHD, the result showed that there were significant difference (RR=0.75; 95% CI [0.60–0.94]; I2=84%; P<0.00001). For death due to infection comparing with LFHD, the result showed that there was no significant difference (RR=0.92; 95% CI [0.75–1.13]; I2=0%; P=0.86). For cardiovascular mortality, the overall meta-analysis result showed that there was a significant difference between the HFHD versus the LFHD (RR=0.75; 95% CI [0.60–0.94]; I2=55%; P=0.11). Publication bias was not detected by funnel plot. Based on these results, our study suggests that the HFHD has superior effectiveness over LFHD for long-term survival in ESRD.
Le texte complet de cet article est disponible en PDF.Keywords : All-cause mortality, Cardiovascular mortality, End-stage renal, Hemodialysis, Meta-analysis
Plan
Vol 13 - N° 1
P. 9-13 - février 2017 Retour au numéro
Article précédent
- Prise en charge de la sténose athéromateuse d’artère rénale en 2016
- Thomas Fournier, Florence Sens, Olivier Rouvière, Antoine Millon, Laurent Juillard
- Tuberculose chez les patients hémodialysés chroniques au Togo : à propos de 10 observations
- Mawufemo Yawovi Tsevi, Akomola Kossi Sabi, Laté Mawuli Lawson-Ananissoh, Befa Noto-Kadou-Kaza, Eyram Yoan Amekoudi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?